StockData
PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc. (PMVP) stock

PMVPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.22+0.03 (+2.52%)

Close on Nov 17, 2026Market cap $65.22MP/E –Yield –

PMV Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

PMV Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$71.27M. For fiscal 2025 it was -$73.58M. The highest annual figure on record is -$15.18M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$73.58M–
FY2024Dec 31, 2024-$51.28M–
FY2023Dec 31, 2023-$55.66M–
FY2022Dec 31, 2022-$63.76M–
FY2021Dec 31, 2021-$46.57M–
FY2020Dec 31, 2020-$32.74M–
FY2019Dec 31, 2019-$22.07M–
FY2018Dec 31, 2018-$15.18M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$14.58M–
Q1 FY2026Mar 31, 2026-$19.68M–
Q4 FY2025Dec 31, 2025-$17.19M–
Q3 FY2025Sep 30, 2025-$19.82M–
Q2 FY2025Jun 30, 2025-$18.30M–
Q1 FY2025Mar 31, 2025-$18.27M–
Q4 FY2024Dec 31, 2024-$16.66M–
Q3 FY2024Sep 30, 2024-$16.84M–
Q2 FY2024Jun 30, 2024-$1.60M–
Q1 FY2024Mar 31, 2024-$16.18M–
Q4 FY2023Dec 31, 2023-$12.09M–
Q3 FY2023Sep 30, 2023-$15.66M–
Q2 FY2023Jun 30, 2023-$12.90M–
Q1 FY2023Mar 31, 2023-$15.01M–
Q4 FY2022Dec 31, 2022-$15.32M–
Q3 FY2022Sep 30, 2022-$16.76M–
Q2 FY2022Jun 30, 2022-$13.68M–
Q1 FY2022Mar 31, 2022-$18.00M–
Q4 FY2021Dec 31, 2021-$12.03M–
Q3 FY2021Sep 30, 2021-$12.40M–
Q2 FY2021Jun 30, 2021-$9.24M–
Q1 FY2021Mar 31, 2021-$12.90M–
Q4 FY2020Dec 31, 2020-$10.31M–
Q3 FY2020Sep 30, 2020-$7.39M–
Q2 FY2020Jun 30, 2020-$6.90M–
Q1 FY2020Mar 31, 2020-$8.14M–
Q4 FY2019Dec 31, 2019-$5.13M–

More PMV Pharmaceuticals figures

See a number that looks wrong?